Ferring Pharmaceuticals to Share New Reproductive Medicine Data at ASRM 2020 Scientific Congress & Expo
Ferring will deliver 11 presentations at the virtual congress; including six oral presentations The new data being presented further underscores…
// //
Ferring will deliver 11 presentations at the virtual congress; including six oral presentations The new data being presented further underscores…
FOR IMMEDIATE RELEASE – Parsippany, NJ – August 5, 2020– Ferring Pharmaceuticals US is voluntarily recalling all lots on the…
ORTIKOS is available in one convenient pill in two dosage strengths (9mg, 6mg) for the treatment of mild to moderate…
Ferring joins with UCB to promote CIMZIA prefilled syringe for Crohn’s disease in the U.S. Co-promotion strengthens commitment to patients…
Ragans is now responsible for Ferring US commercial, manufacturing and development operations Ragans joined Ferring, a world leader in reproductive…
MEGASET-HR (high responder) study met its primary non-inferiority endpoint, with Menopur-treated patients experiencing a 35.5% ongoing pregnancy rate (OPR) per…
Rebiotix and Ferring are the first to announce positive preliminary results on primary efficacy endpoint from ongoing pivotal Phase 3…
Fertility House Calls service offered to residents of Greater Denver metro area as part of a pilot program Personalized service…
The multi-center study met its primary endpoint with 53% of CIS ± Ta/T1 patients achieving a complete response (CR) at…
Ferring launches new company FerGene, with a focus on the global development and US commercialization of nadofaragene firadenovec, for high-grade,…